Single-Dose Study of MT203

NCT02354599 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: MT203 80 mg or matching Placebo
DRUG: MT203 150mg or matching Placebo
DRUG: MT203 300 mg or matching placebo

Sponsor

Takeda